Posted by Michael Wonder on 23 Jun 2021
PBS listings to support patients with mesothelioma
23 June 2021 - From July 1, thousands of Australians and their families suffering from rare cancers and genetic disorders are set to benefit from expanded listings on the PBS.
We are expanding the listing for Opdivo and Yervoy (nivolumab and ipilimumab), for the treatment of patients with unresectable malignant mesothelioma.
Our Government is also expanding the listing of Kuvan (sapropterin) on the PBS to include treatment of maternal phenylketonuria.
